These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16785987)

  • 1. Fusion tyrosine kinases: a result and cause of genomic instability.
    Penserga ET; Skorski T
    Oncogene; 2007 Jan; 26(1):11-20. PubMed ID: 16785987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability.
    Skorski T
    Oncogene; 2002 Dec; 21(56):8591-604. PubMed ID: 12476306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
    Sallmyr A; Fan J; Rassool FV
    Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.
    Slupianek A; Hoser G; Majsterek I; Bronisz A; Malecki M; Blasiak J; Fishel R; Skorski T
    Mol Cell Biol; 2002 Jun; 22(12):4189-201. PubMed ID: 12024032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.
    Turner SD; Alexander DR
    Leukemia; 2006 Apr; 20(4):572-82. PubMed ID: 16482213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
    Rassool FV; Gaymes TJ; Omidvar N; Brady N; Beurlet S; Pla M; Reboul M; Lea N; Chomienne C; Thomas NS; Mufti GJ; Padua RA
    Cancer Res; 2007 Sep; 67(18):8762-71. PubMed ID: 17875717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise review of DNA damage checkpoints and repair in mammalian cells.
    Houtgraaf JH; Versmissen J; van der Giessen WJ
    Cardiovasc Revasc Med; 2006; 7(3):165-72. PubMed ID: 16945824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
    Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
    Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair.
    Scassa ME; Marazita MC; Ceruti JM; Carcagno AL; Sirkin PF; González-Cid M; Pignataro OP; Cánepa ET
    DNA Repair (Amst); 2007 May; 6(5):626-38. PubMed ID: 17218167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance.
    Pytel D; Wysocki T; Majsterek I
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Sep; 144(1):85-92. PubMed ID: 16904383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen receptor diversification and chromosome translocations.
    Jankovic M; Nussenzweig A; Nussenzweig MC
    Nat Immunol; 2007 Aug; 8(8):801-8. PubMed ID: 17641661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors and genomic instability.
    Eot-Houllier G; Fulcrand G; Magnaghi-Jaulin L; Jaulin C
    Cancer Lett; 2009 Feb; 274(2):169-76. PubMed ID: 18635312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: role in drug resistance?
    Hoser G; Majsterek I; Romana DL; Slupianek A; Blasiak J; Skorski T
    Leuk Res; 2003 Mar; 27(3):267-73. PubMed ID: 12537980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
    Stoklosa T; Poplawski T; Koptyra M; Nieborowska-Skorska M; Basak G; Slupianek A; Rayevskaya M; Seferynska I; Herrera L; Blasiak J; Skorski T
    Cancer Res; 2008 Apr; 68(8):2576-80. PubMed ID: 18413724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression.
    Shields BJ; Hauser C; Bukczynska PE; Court NW; Tiganis T
    Cancer Cell; 2008 Aug; 14(2):166-79. PubMed ID: 18691551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
    Wiltshire T; Senft J; Wang Y; Konat GW; Wenger SL; Reed E; Wang W
    Mol Pharmacol; 2007 Apr; 71(4):1051-60. PubMed ID: 17229870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.